–
Moleculin Biotech, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−23.0
FY22:
−30.6
FY23:
−29.6
FY24:
−26.6
FY25:
−25.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−29.5
FY22:
−31.8
FY23:
−28.5
FY24:
–
FY25:
−16.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−15.9
FY22:
−29.0
FY23:
−29.8
FY24:
−26.0
FY25:
−33.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−15.9
FY22:
−29.0
FY23:
−29.8
FY24:
−26.0
FY25:
−33.6
All amounts in millions USD